Cart
sales@molnova.com
Adafosbuvir PM
CAS No. 1613589-04-0
Adafosbuvir PM( —— )
Catalog No. M35984 CAS No. 1613589-04-0
Adafosbuvir PM (AL-335 PM) is a small molecule NS5B inhibitor that can be used to study chronic hepatitis C.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 395 | Get Quote |
|
| 5MG | 614 | Get Quote |
|
| 10MG | 873 | Get Quote |
|
| 25MG | 1270 | Get Quote |
|
| 50MG | 1711 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAdafosbuvir PM
-
NoteResearch use only, not for human use.
-
Brief DescriptionAdafosbuvir PM (AL-335 PM) is a small molecule NS5B inhibitor that can be used to study chronic hepatitis C.
-
DescriptionAdafosbuvir PM (AL-335 PM) is a small molecule NS5B inhibitor that can be used to study chronic hepatitis C.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorHCV Protease
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1613589-04-0
-
Formula Weight276.22
-
Molecular FormulaC10H13FN2O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@]1(O)[C@@H](O[C@@](CO)(F)[C@H]1O)N2C(=O)NC(=O)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
EN300-203561
EN300-203561
-
FATP1-IN-1
FATP1-IN-1 is a potent inhibitor of fatty acid transport protein 1 (FATP1). It effectively inhibits the activity of recombinant human or mouse acyl-CoA synthetase, which is essential for the function of FATP1.
-
Ianalumab
Ianalumab (VAY-736) is a decarboxylated humanized antibody against BAFF-R that inhibits the interaction between BAFF and BAFF-R, blocking BAFF-mediated apoptosis protection.
